Literature DB >> 19277430

The significance of ADAMTS13 in a patient with thrombotic thrombocytopenic purpura complicated autoimmune hepatitis.

Michiomi Shimizu, Shosaku Nomura, Kazuyoshi Ishii, Youichi Mohri, Nao Umei, Satoshi Suzuki, Yoshio Matsuo, Ayami Isonishi, Masanori Matsumoto, Fumiaki Urase, Yasuhiro Maeda, Yoshihiro Fujimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19277430

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy.

Authors:  Yoshitaka Miyakawa; Kazunori Imada; Tatsuo Ichinohe; Kenji Nishio; Takayuki Abe; Mitsuru Murata; Yasunori Ueda; Yoshihiro Fujimura; Masanori Matsumoto; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2016-05-17       Impact factor: 2.490

2.  Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hepatol       Date:  2011-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.